McDonald's stock was cut from buy to sell over a potential double-digit loss in sales due to weight-loss drugs.

Novo Nordisk (NYSE:NVO) rose to its highest level in over two months Monday after a media report said hedge fund Parvus Asset ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

UBS is holding firm on its Buy rating and $1,050 price target for Eli Lilly, driven by faith in the upcoming SURPASS-CVOT ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...

Pfizer's stock experienced a 2.66% increase on June 9, 2025, closing at $23.97, marking its second consecutive day of gains.

Companies are always in the race for the top spot, and the only way to achieve it is by reaching a high market valuation. The ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Business Model Mastery’s Substack. In this article, we will ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Chugai plans to pair its muscle-preserving drug with Eli Lilly's orforglipron, addressing muscle loss in obesity care as the ...

Following the release of upbeat data and given some recent signs of stabilization in the stocks, MarketWatch took at look at companies in the healthcare sector that are expected to produce the fastest ...